The FDA’s gag rule on off-label treatments

Michael Cannon, director of health policy studies for the Cato Institute, talks about the gag rule that places restrictions on discussing legal uses of drugs for off-label purposes, as well as a bill that would make trial drugs available to terminally ill patients.

Comments

Of Consuming Interest

SUNDAYS at 10:30 P.M.

Of Consuming Interest is a weekly show examining the most important consumer issues today. Shirley can be reached via email at shirley@callforaction.org. Subscribe on Apple Podcasts or Podcast One.

Sign up for breaking news alerts